Sensus Healthcare Inc. (SRTS)
NASDAQ: SRTSHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SRTS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $37.20M
- EPS (TTM)
- -$0.97
- Dividend yield
- None
- 52-week range
- 2.14 – 5.49
- Day range
- 2.22 – 2.41
- Volume / Avg
- 122.02K / 208.74K
- Beta
- —
- Shares outstanding
- 16.46M
52-week range
SRTS stock today
Sensus Healthcare (SRTS) closed at $2.26 on Nov 20, down 4.24% (-$0.10), versus the S&P 500's 3.70% decline. At this level, SRTS sits near the bottom of its 52-week range of $2.14 to $5.49: 58.8% below the high, set on Jan 13, 2026 and 5.6% above the low. SRTS is down 43.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 43.8%.
Sensus Healthcare has posted a net loss over the last twelve months (EPS of -$0.97), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Sensus Healthcare
Company profileSensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Joseph C. Sardano
- Headquarters
- Boca Raton, FL
- Employees
- 60
- IPO year
- 2016
- Website
- sensushealthcare.com
Financial highlights
Full financialsIn fiscal 2025, Sensus Healthcare generated $27.5 million in revenue, down 34.3% from fiscal 2024, its first annual decline since 2023. Sensus Healthcare reported a net loss of $7.7 million, compared with net income of $6.6 million a year earlier. Gross margin was 43.2% (down from 58.4%) and operating margin -37.5%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $27.48M | $41.81M | $24.41M | $44.53M | $27.04M |
| Growth | -34.26% | +71.31% | -45.20% | +64.68% | +182.36% |
| Net income | $-7.72M | $6.65M | $485.00K | $24.24M | $4.12M |
| EPS (diluted) | $-0.47 | $0.41 | $0.03 | $1.46 | $0.25 |
Analyst forecast
ForecastConsensus (4 analysts)
none
Avg. price target
$5.38+138.05%
- Strong buy 1
- Buy 3
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 12, 2026
- EPS actual vs est.
- $-0.06 vs —
SRTS news
All SRTS news- Sensus Healthcare (SRTS) Q3 2026 Earnings Call TranscriptNasdaq
- Sensus Healthcare Reports Third Quarter 2026 Financial Results and Business HighlightsBusiness Wire
- Sensus Healthcare to Report Third Quarter 2026 Financial Results and Hold Business Update Conference Call on November 12, 2026Business Wire
Sensus Healthcare peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MDAISpectral AI Inc. Class A | 1.04 | -20.61% | $33.47M | vs SRTS |
| TELATELA Bio Inc. | 0.6885 | -5.27% | $31.11M | vs SRTS |
| DXRDaxor Corporation | 7.45 | -7.33% | $43.49M | vs SRTS |
| XTNTXtant Medical Holdings Inc. | 0.21 | -2.82% | $29.49M | vs SRTS |
| NSPRInspireMD Inc. | 0.54 | -12.97% | $29.23M | vs SRTS |
| MBOTMicrobot Medical Inc. | 0.68 | -8.52% | $45.67M | vs SRTS |
| NEPHNephros Inc. | 2.61 | -8.10% | $28.37M | vs SRTS |
| PLRZPolyrizon Ltd. | 9.31 | -8.42% | $22.61M | vs SRTS |
Indexes, lists and sector
Sensus Healthcare stock FAQ
What is Sensus Healthcare's stock price today?
SRTS last traded at $2.26 as of Nov 20, 4:00 PM EST, down 4.24% on the day. Prices are delayed at least 15 minutes.
Who is Sensus Healthcare's CEO?
Mr. Joseph C. Sardano is the chief executive officer of Sensus Healthcare Inc., which has about 60 employees.
What is the SRTS 52-week high?
The 52-week high for SRTS is $5.49 and the 52-week low is $2.14. The stock is currently 58.8% below its high.